Seizure News and Research

Latest Seizure News and Research

Biogen Idec receives FDA approval for two separate dosing innovations to treat MS

Today Biogen Idec announced that the U.S. Food and Drug Administration (FDA) has approved two separate dosing innovations designed to improve the treatment experience for patients receiving once-a-week AVONEX for relapsing forms of multiple sclerosis (MS).

28 Feb 2012

FDA to review rejected weight loss drug Qnexa

The weight loss pill Qnexa has been once rejected by the FDA over safety concerns. But this Wednesday it will get a second chance before an FDA advisory committee. Qnexa maker Vivus Inc. hopes something might come out of this second chance. The company will be submitting new safety data from patients who took Qnexa for a second year after completing a one-year clinical trial.

21 Feb 2012

Substituting antiepileptic drugs may lead to increase in risk of epilepsy

The substitution of brand-name antiepileptic drugs with cheaper generic equivalents has been an ongoing point of contention among doctors, federal officials and people with epilepsy.

18 Feb 2012

Midazolam autoinjector pen more effective in treating status epilepticus

Results have just been released from an NIH study conducted at multiple sites, including the University of Kentucky, indicating that an autoinjector pen is a faster and possibly more effective way for emergency medical personnel to treat serious seizures.

17 Feb 2012

Intramuscular midazolam effective in treating status epilepticus

Drug delivery directly into muscle using an autoinjector is faster and may be more effective in stopping prolonged seizures, according to a study sponsored by the National Institutes of Health and conducted by a Wayne State University School of Medicine researcher.

17 Feb 2012

Epilepsy community concerned over AHRQ's AED drug comparison study

Leading representatives of the American Epilepsy Society, American Academy of Neurology, and the Epilepsy Foundation today reported they have grave concerns about the implications and potential misuse of the anticonvulsant (AED) drug comparisons study recently released by the U.S. Agency for Health Research and Quality.

17 Feb 2012

Acorda's fourth quarter GAAP net income increases to $12.7 million

Acorda Therapeutics, Inc. today announced its financial results for the fourth quarter and full year ended December 31, 2011.

16 Feb 2012

Rapid intramuscular injection of midazolam drug is safe, effective for status epilepticus

When a person is experiencing a prolonged convulsive seizure, quick medical intervention is critical. With every passing minute, the seizure becomes harder to stop, and can place the patient at risk of brain damage and death. This is why paramedics are trained to administer anticonvulsive medications as soon as possible -- traditionally giving them intravenously before arriving at the hospital.

16 Feb 2012

Midazolam autoinjector may effectively treat status epilepticus

Drug delivery into muscle using an autoinjector, akin to the EpiPen used to treat serious allergic reactions, is faster and may be a more effective way to stop status epilepticus, a prolonged seizure lasting longer than five minutes, according to a study sponsored by the National Institutes of Health. Status epilepticus is a potentially life-threatening emergency that causes 55,000 deaths each year.

16 Feb 2012

New group of compounds may protect brain cells from inflammation

Scientists at Emory University School of Medicine have identified a new group of compounds that may protect brain cells from inflammation linked to seizures and neurodegenerative diseases.

15 Feb 2012

Risk of obstetric intervention lower for women who intended home births

In a study to be presented today at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting -, in Dallas, Texas, researchers will report findings that indicate that the risk of obstetric intervention is lower for women who deliver or intend to deliver outside of hospitals, but there are some higher risks for newborns intended for home births compared to hospital births.

13 Feb 2012

Deep brain stimulation helps improve memory and cognitive skills in epilepsy patients

Researchers have found that deep brain stimulation by sending in electric shocks to a part of the brain that plays a key role in memory improved people's ability to learn. This could raise hope for patients of Alzheimer’s.

12 Feb 2012

SSRIs may minimize risk of Sudden Unexpected Death in Epilepsy

A groundbreaking study published in Elsevier's Epilepsy & Behavior provides evidence in mouse model that drugs known as Selective Serotonin Reuptake Inhibitors (SSRIs; one category of antidepressants) may reduce the risk of Sudden Unexpected Death in Epilepsy (SUDEP).

9 Feb 2012

Epilepsy surgery improves QOL and long-term seizure control

While epilepsy surgery is a safe and effective intervention for seizure control, medical therapy remains the more prominent treatment option for those with epilepsy. However, a new 26-year study reveals that following epilepsy surgery, nearly half of participants were free of disabling seizures and 80% reported better quality of life than before surgery.

7 Feb 2012

FDA clears Neurelis IND to commence NRL-1 clinical trials for acute breakthrough seizures

Neurelis, Inc. today announced that the United States Food and Drug Administration (FDA) has cleared an Investigational New Drug application (IND) to commence clinical trials advancing the development of NRL-1 for the treatment of acute breakthrough seizures.

7 Feb 2012

FDA faces legal attack over alleged spying on whistleblowers

A latest lawsuit filed in federal court has accused the Food and Drug Administration (FDA) of electronically spying on whistleblowers who alerted the Obama administration and Congress of alleged misconduct in the agency, particularly relating to what they claim was the push to approve unsafe and ineffective medical devices.

31 Jan 2012

Mystery teen neurological illness followed up by Erin Brockovich meets resistance

Famous environmental activist Erin Brockovich’s team faced resistance as they tried to test the area around an upstate New York school for clues to a case involving more than a dozen teens plagued by mysterious Tourette's-like symptoms and seizures. One neurologist who has seen most of the affected girls has diagnosed their illness as psychological in origin, but some parents and members of the community have disputed that diagnosis.

30 Jan 2012

Researchers develop new MRS technique to diagnose brain tumors

Researchers at UT Southwestern Medical Center have developed what they believe to be the first clinical application of a new imaging technique to diagnose brain tumors.

30 Jan 2012

FDA approves UCB's Keppra for treatment of partial onset seizures in infants

UCB announced today that the U.S. Food and Drug Administration (FDA) has approved Keppra (levetiracetam) tablets and oral solution as adjunctive therapy in the treatment of partial onset seizures in adults and children one month of age and older with epilepsy.

27 Jan 2012

Roundup: N.Y. insurers to update directories; Cook county, Ill. health fees fall short; Md. woman says hospital denied same-sex visitation

New York Attorney General Eric Schneiderman says his office has reached settlements with eight health insurance companies that require them to ensure the accuracy of provider directories on their websites. The attorney general's office says the companies will remove names of doctors and other providers who no longer participate and correct listing errors for others.

20 Jan 2012

Seizure News and Research

Latest Seizure News and Research

Biogen Idec receives FDA approval for two separate dosing innovations to treat MS

FDA to review rejected weight loss drug Qnexa

Substituting antiepileptic drugs may lead to increase in risk of epilepsy

Midazolam autoinjector pen more effective in treating status epilepticus

Intramuscular midazolam effective in treating status epilepticus

Epilepsy community concerned over AHRQ's AED drug comparison study

Acorda's fourth quarter GAAP net income increases to $12.7 million

Rapid intramuscular injection of midazolam drug is safe, effective for status epilepticus

Midazolam autoinjector may effectively treat status epilepticus

New group of compounds may protect brain cells from inflammation

Risk of obstetric intervention lower for women who intended home births

Deep brain stimulation helps improve memory and cognitive skills in epilepsy patients

SSRIs may minimize risk of Sudden Unexpected Death in Epilepsy

Epilepsy surgery improves QOL and long-term seizure control

FDA clears Neurelis IND to commence NRL-1 clinical trials for acute breakthrough seizures

FDA faces legal attack over alleged spying on whistleblowers

Mystery teen neurological illness followed up by Erin Brockovich meets resistance

Researchers develop new MRS technique to diagnose brain tumors

FDA approves UCB's Keppra for treatment of partial onset seizures in infants

Roundup: N.Y. insurers to update directories; Cook county, Ill. health fees fall short; Md. woman says hospital denied same-sex visitation

Everything you need to know about epilepsy eBook

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

How does norepinephrine influence anxiety-related behaviours?

Seizure News and Research

Latest Seizure News and Research

Everything you need to know about epilepsy eBook

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

How does norepinephrine influence anxiety-related behaviours?

Newsletters you may be interested in